Association of tuberculosis and polymorphisms in the promoter region of macrophage migration inhibitory factor (MIF) in a Southwestern China Han population

Cytokine

Volumn 60, Issue 1, 2012, Pages 64-67

  Li, Yanlin ^a,b   Yuan, Tao ^a   Lu, Weiping ^a   Chen, Ming ^a   Cheng, Xiaoxing ^c   Deng, Shaoli ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b The people's Hospital of Yubei District   (China)

^c 309TH HOSPITAL OF PLA   (China)

Author keywords

Migration inhibitory factor; SNP; Tuberculosis

Indexed keywords

GENOMIC DNA; MACROPHAGE MIGRATION INHIBITION FACTOR;

ADULT; ARTICLE; CHINA; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MACROPHAGE MIGRATION INHIBITORY FACTOR GENE; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TUBERCULOSIS;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS;

EID: 84865442091     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.06.010     Document Type: Article

References (22)

1. World Health Organization. Global tuberculosis control: epidemiology, strategy, financing. WHO report; 2010.
2. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO; 2007.
3. Corbett E.L., Watt C.J., Walker N., Maher D., Williams B.G., Raviglione M.C., et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 2003, 163:1009-1021.
4. Bloom B.R., Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966, 153:80-82.
5. David J.R. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA 1966, 56(1):72-77.
6. Calandra T., Roger T. Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immun 2003, 791-800.
7. Martinez A., Orozco G., Varade J., Lopez M.S., Pascual D., Balsa A., et al. Macrophage migration inhibitory factor gene: influence on rheumatoid arthritis susceptibility. Hum Immun 2007, 68:744-747.
8. Yamada G., Shijubo N., Takagi-Takahashi Y., Nishihira J., Mizue Y., Kikuchi K., et al. Elevated levels of serum macrophage migration inhibitory factor in patients with pulmonary tuberculosis. Clin Immun 2002, 104:123-127.
9. Oddo M., Calandra T., Bucala R., Meylan Pascal R.A., et al. Macrophage migration inhibitory factor reduces the growth of virulent Mycobacterium tuberculosis in human macrophages. Infect Immun 2005, 73:3783-3786.
10. Donn R., Alourfi Z., De Benedetti F., Meazza C., Zeggini E., Lunt M., et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthrit Rheum 2002, 46(9):2402-2409.
11. Baugh J.A., Chitnis S., Donnelly S.C., Monteiro J., Lin X., Plant B.J., et al. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis. Genes Immun 2002, 3(3):170-176.
12. Wu J., Chen F., Zhang X.L., Li Y.Z., Ma H.Y., Zhou Y.C., et al. Association of MIF promoter polymorphisms with psoriasis in a han population in northeastern China. J Dermatol Sci 2009, 53:212-215.
13. Leung K.H., Yip S.P., Wong W.S., Yiu L.S., Chan K.K., Lai W.M., et al. Sex - and age - dependent association of SLC11A1 polymorphisms with tuberculosis in Chinese: a case control study. BMC Infect Dis 2007, 7:19.
14. Babb C., van der Merwe L., Beyers N., Pheiffer C., Walzl G., Duncan K., et al. Vitamin D receptor gene polymorphisms and sputum conversion time in pulmonary tuberculosis patients. Tuberculosis 2007, 87:295-302.
15. Delgado J.C., Baena A., Thim S., Goldfeld Anne E., et al. Aspartic acid homozygosity at codon 57 of HLA-DQ is associated with susceptibility to pulmonary tuberculosis in Cambodia. J Immunol 2006, 176:1090-1097.
16. El Sahly H.M., Reich R.A., Dou S.J., Musser J.M., Graviss E.A., et al. The effect of mannose binding lectin gene polymorphisms on susceptibility to tuberculosis in different ethnic groups. Scand J Infect Dis 2004, 36(2):106-108.
17. Tosh K., Campbell S.J., Fielding K., Sillah J., Bah B., Gustafson P., et al. Variants in the SP110 gene are associated with genetic susceptibility to tuberculosis in West Africa. Proc Natl Acad Sci USA 2006, 103:10364-10368.
18. Velez D.R., Hulme W.F., Myers J.L., Weinberg J.B., Lecesque M.C., Stryjewski M.E., et al. NOS2A, TLR4, and IFNGR1 interactions influence pulmonary tuberculosis susceptibility in African-Americans. Hum Genet 2009, 126:643-653.
19. Gomez L.M., Sanchez E., Ruiz-Narvaez E.A., Lopez-Nevot M.A., Anaya J.M., Martin J., et al. Macrophage migration inhibitory factor gene influences the risk of developing tuberculosis in northwestern Colombian population. Tissue Antigens 2007, 70:28-33.
20. Sadki K., Lamsyah H., Rueda B., Akil E., Sadak A., Martin J., et al. Analysis of MIF, FCGR2A and FCGR3A gene polymorphisms with susceptibility to pulmonary tuberculosis in Moroccan population. J of Genet and Genom 2010, 37:257-264.
21. Temple S.E., Cheong K.Y., Price P., Waterer G.W., et al. The microsatellite, macrophage migration inhibitory factor -794, may influence gene expression in human mononuclear cells stimulated with E. coli or S. pneumoniae. Int J Immunogenet 2008, 35:309-316.
22. Shiroeda H., Tahara T., Nakamura M., Shibata T., Nomura T., Yamada H., et al. Association between functional promoter polymorphisms of macrophage migration inhibitory factor (MIF) gene and ulcerative colitis in Japan. Cytokine 2010, 51:173-177.